Difference between the abilities of human Fcγ receptor-Expressing CV-1 cells to neutralize American and Asian Genotypes of dengue virus 2

Clinical and Vaccine Immunology

Volumn 16, Issue 2, 2009, Pages 285-287

  Rodrigo, W W I S ^a   Alcena, D C ^a   Kou, Z ^a   Kochel, T J ^b   Porter, K R ^c   Comach, G ^d   Rose, R C ^a   Jin, X ^a   Schlesinger, J J ^a,e  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b California   (Peru)

^c NAVAL MEDICAL RESEARCH CENTER   (United States)

^d Laboratorio Regional de Diagnostico e   (Venezuela)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD32 ANTIGEN; FC RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; EPIDEMIC; GENOTYPE; HUMAN; NONHUMAN; PERU; PRIORITY JOURNAL; VIRUS NEUTRALIZATION; VIRUS PLAQUE; VIRUS TYPING; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CROSS REACTIONS; DENGUE VIRUS; GENOTYPE; HUMANS; NEUTRALIZATION TESTS; PLAQUE ASSAY; RECEPTORS, IGG;

EID: 59649120284     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00363-08     Document Type: Article

References (15)

1. Chareonsirisuthigul, T., S. Kalayanarooj, and S. Ubol. 2007. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J. Gen. Virol. 88:365-375.
2. Cologna, R., and R. Rico-Hesse. 2003. American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J. Virol. 77:3929-3938.
3. Guzman, M. G., G. P. Kouri, J. Bravo, M. Soler, S. Vazquez, and L. Morier. 1990. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepide- miologic study. Am. J. Trop. Med. Hyg. 42:179-184.
4. Halstead, S. B., and P. Simasthien. 1970. Observations related to the patho-genesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host. Yale J. Biol. Med. 42:276-292.
5. Kochel, T. J., D. M. Watts, S. B. Halstead, C. G. Hayes, A. Espinoza, V. Felices, R. Caceda, C. T. Bautista, Y. Montoya, S. Douglas, and K. L. Russell. 2002. Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet 360:310-312.
6. Kou, Z., M. Quinn, H. Chen, W. W. Rodrigo, R. C. Rose, J. J. Schlesinger, and X. Jin. 2008. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mono-nuclear cells. J. Med. Virol. 80:134-146.
7. Mahalingam, S., and B. A. Lidbury. 2002. Suppression of lipopolysaccha-ride-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus. Proc. Natl. Acad. Sci. USA 99:13819-13824.
8. Munoz-Jordan, J. L., G. G. Sanchez-Burgos, M. Laurent-Rolle, and A. Gar-cia-Sastre. 2003. Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. USA 100:14333-14338.
9. Parren, P. W., and D. R. Burton. 2001. The antiviral activity of antibodies in vitro and in vivo. Adv. Immunol. 77:195-262.
10. Rico-Hesse, R. 2007. Dengue virus evolution and virulence models. Clin. Infect. Dis. 44:1462-1466.
11. Rodrigo, W. W., D. C. Alcena, R. C. Rose, X. Jin, and J. J. Schlesinger. An automated dengue virus microneutralization plaque assay performed in human Fcγ receptor-expressing CV-1 cells. Am. J. Trop. Med. Hyg., in press.
12. Rodrigo, W. W., X. Jin, S. D. Blackley, R. C. Rose, and J. J. Schlesinger. 2006. Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human FcγRIA (CD64) or FcγRIIA (CD32). J. Virol. 80:10128-10138.
13. Roehrig, J. T. 2007. Guidelines for plaque reduction neutralization testing of human antibodies to dengue viruses, p. 1-23. World Health Organization, Geneva, Switzerland.
14. Vaughn, D. W., S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, T. P. Endy, B. Raengsakulrach, A. L. Rothman, F. A. Ennis, and A. Nisalak. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181:2-9.
15. Watts, D. M., K. R. Porter, P. Putvatana, B. Vasquez, C. Calampa, C. G. Hayes, and S. B. Halstead. 1999. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 354:1431-1434.